Advertisement

PharmacoEconomics & Outcomes News

, Volume 823, Issue 1, pp 4–4 | Cite as

Alirocumab too costly to be cost effective after MI

Clinical study
  • 5 Downloads

Reference

  1. Kazi DS, et al. Cost-Effectiveness of Alirocumab: A Just-in-Time Analysis Based on the ODYSSEY Outcomes Trial. Annals of Internal Medicine 170: 221-230, No. 4, 19 Feb 2019. Available from: URL: http://dx.doi.org/10.7326/M18-1776Google Scholar

Copyright information

© Springer International Publishing AG 2019

Personalised recommendations